Fluphenazine DiHCl - CAS 146-56-5
Catalog number:
146-56-5
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C22H28F3N3OSCl2
Molecular Weight:
510.45
COA:
Inquire
Targets:
Dopamine Receptor
Description:
Fluphenazine DiHCl is the dihydrochloride salt preparation of Fluphenazine. It has been used to deliver Fluphenazine to biological systems in studies probing the effects and metabolic fates of this commonly used dopamine antagonist.
Publictions citing BOC Sciences Products
  • >> More
Purity:
> 95%
Appearance:
White to Off-White Solid
Synonyms:
4-[3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl]-1-piperazineethanol Dihydrochloride;Anatensol;Dapotum;Flufenazin;Tensofin;Permitil hydrochloride;Prolinate;Prolixin;Siqualone;Squibb 4918;Trancin;Valamina;Fluphenazine Decanoate EP Impurity B DiHCl
Solubility:
Soluble to 38mg/mL in DMSO
Storage:
Store in a cool and dry place and at 0 - 4℃ for short term (days to weeks) or -77℃ for long term (months to years).
MSDS:
Inquire
Shelf Life:
2 years
Quantity:
Grams-Kilos
Melting Point:
235-237 °C
InChIKey:
MBHNWCYEGXQEIT-UHFFFAOYSA-N
InChI:
1S/C22H26F3N3OS.2ClH/c23-22(24,25)17-6-7-21-19(16-17)28(18-4-1-2-5-20(18)30-21)9-3-8-26-10-12-27(13-11-26)14-15-29;;/h1-2,4-7,16,29H,3,8-15H2;2*1H
Canonical SMILES:
C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO.Cl.Cl
1.Electrocatalysis of NADH oxidation using electrochemically activated fluphenazine on carbon nanotube electrode.
Sobczak A1, Rębiś T2, Milczarek G3. Bioelectrochemistry. 2015 Dec;106(Pt B):308-15. doi: 10.1016/j.bioelechem.2015.07.002. Epub 2015 Jul 13.
Electrocatalytic determination of NADH using a hybrid surface-modified electrode with multi-wall carbon nanotubes (MWCNTs) and a novel electrogenerated redox mediator is described. The redox mediator precursor - fluphenazine (Flu) was adsorbed on MWCNT-modified glassy carbon (GC) electrode which was then subjected to electrochemical activation in 0.1 M H2SO4 using cyclic voltammetry (CV) over a range of potentials -0.2 to 1.5 V vs. Ag/AgCl (6 scans at 100 mV s(-1)). Cyclic voltammograms of Flu indicated the formation of a stable electroactive material presenting one reversible redox couple at the formal potential of -0.115 vs. Ag/AgCl in a phosphate buffer (pH7.0) as a supporting electrolyte. The peaks increased linearly with increasing scan rate indicating electroactive molecules anchored to the electrode surface. The GC/MWCNT/Flu electrode efficiently catalyzed the oxidation of NADH with a decrease in the overpotential of about 600 mV and 150 mV compared to the bare GC and GC/MWCNT electrode, respectively.
2.Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital Discharge.
Marcus SC1, Zummo J, Pettit AR, Stoddard J, Doshi JA. J Manag Care Spec Pharm. 2015 Sep;21(9):754-68.
BACKGROUND: Antipsychotic medications are a central component of effective treatment for schizophrenia, but nonadherence is a significant problem for the majority of patients. Long-acting injectable (LAI) antipsychotic medications are a recommended treatment option for nonadherent patients, but evidence regarding their potential advantages has been mixed. Observational data on newer, second-generation LAI antipsychotic medications have been limited given their more recent regulatory approval and availability.
3.Forced Degradation Behaviour of Fluphenazine Hydrochloride by LC and Characterization of its Oxidative Degradation Product by LC-MS/MS.
Thummar KN1, Ghava DJ1, Mistry A1, Vachhani A1, Sheth NR1. Sci Pharm. 2014 Dec 22;83(2):297-309. doi: 10.3797/scipharm.1411-04. eCollection 2015.
A novel, stability-indicating high-performance liquid chromatographic (HPLC) method is delivered for the determination of fluphenazine hydrochloride (FPZ) and its degradation products. The forced degradation testing of FPZ was carried out for hydrolytic, oxidative, photolytic, and thermal degradation. The degradation appeared using a reversed-phase C18 column at ambient temperature with a mobile phase comprised of methanol : acetonitrile : (10 mM) ammonium acetate (70:15:15, v/v/v) pH 6.0, adjusted with acetic acid, having a flow rate of 1 ml min(-1) and a detection wavelength at 259 nm. Primarily, the maximum degradation products were formed under oxidative stress conditions. The product was distinguished through LC-MS/MS fragmentation studies. Based on the results, a more complete degradation pathway for the drug could be proposed. The modernized method was found to be precise, accurate, specific, and selective. The method was found to be suitable for the quality control of fluphenazine hydrochloride in the tablet as well as in stability-indicating studies.
4.Comparison of treatment effectiveness and medical costs for different long-acting injectable antipsychotics in patients with schizophrenia in Taiwan: A nationwide population-based cohort study.
Wu CS1, Cheng IC2, Feng J2, Chen CL3. Schizophr Res. 2016 Mar 14. pii: S0920-9964(16)30091-3. doi: 10.1016/j.schres.2016.02.037. [Epub ahead of print]
OBJECTIVE: To assess the comparative effectiveness and medical costs of five long-acting injectable (LAI) antipsychotics, flupentixol, fluphenazine, haloperidol, risperidone, and clopentixol/zuclopentixol, in patients with schizophrenia.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Dopamine Receptor Products


CAS 66644-81-3 Veralipride

Veralipride
(CAS: 66644-81-3)

Veralipride is a D2 receptor antagonist in the hypothalamic system and has a half-life of approximately 12 hours. Veralipride is highly active on the neurotrans...

CAS 81409-90-7 Cabergoline

Cabergoline
(CAS: 81409-90-7)

Cabergoline is a lysergic acid amide derivative and a potent dopamine D2 receptor agonist. It has been used for monotherapy of Parkinson′s disease in the early ...

CAS 23672-07-3 Levosulpiride

Levosulpiride
(CAS: 23672-07-3)

Levosulpiride is a selective antagonist for D2 dopamine receptors used as an antipsychotic and prokinetic agent.Levosulpiride is used in the treatment of psycho...

CAS 104632-27-1 Pramipexole impurity D

Pramipexole impurity D
(CAS: 104632-27-1)

The dihydrochloride salt form of dexpramipexole, also known as R-(+)-Pramipexole, is one of the impurities of pramipexole. It coule be used as a negative contro...

CAS 170381-16-5 Zicronapine

Zicronapine
(CAS: 170381-16-5)

Zicronapine, an inden derivative, has been found to be neurotransmitter receptor modulators of sorts of neurotransmitter and was studied against Schizophrenia.

CAS 146-54-3 Triflupromazine

Triflupromazine
(CAS: 146-54-3)

Triflupromazine, a phenothiazin derivative, has been found to be a D2 dopamine receptor antagonist that could probably used as a tranquilizer and antipsychotic ...

CAS 215803-78-4 Sb-277011

Sb-277011
(CAS: 215803-78-4)

Sb-277011 is a novel, high-anity and selective dopamine D3 receptor antagonist that may have potential in treating the negative symptoms of schizophrenia. pKi:...

CAS 52-86-8 Haloperidol

Haloperidol
(CAS: 52-86-8)

Haloperidol (Haldol) is an antipsychotic and butyrophenone.

CAS 269718-84-5 Pardoprunox

Pardoprunox
(CAS: 269718-84-5)

Pardoprunox, also called as SLV308 or DU-126891, is a D2 (pKi = 8.1) and D3 receptor (pKi = 8.6) partial agonist (IA = 50% and 67%, respectively) and 5-HT1A rec...

CAS 146-56-5 Fluphenazine DiHCl

Fluphenazine DiHCl
(CAS: 146-56-5)

Fluphenazine DiHCl is the dihydrochloride salt preparation of Fluphenazine. It has been used to deliver Fluphenazine to biological systems in studies probing th...

CAS 62-31-7 Dopamine HCl

Dopamine HCl
(CAS: 62-31-7)

Dopamine HCl is a catecholamine neurotransmitter present in a wide variety of animals, and a dopamine D1-5 receptors agonist.

CAS 132810-10-7 Blonanserin

Blonanserin
(CAS: 132810-10-7)

A 5-HT2 serotonin receptor and D2 dopamine receptor antagonist, used as an antipsychotic.

CAS 51012-33-0 Tiapride hydrochloride

Tiapride hydrochloride
(CAS: 51012-33-0)

Tiapride is a D2 and D3 dopamine receptor antagonist used to treat a variety of neurological and psychiatric disorders.

CAS 152886-85-6 U91356

U91356
(CAS: 152886-85-6)

U91356 exhibits good dopaminergic agonist activity, and has improved metabolic stability and oral bioavailability in the rat and monkey.

CAS 57808-66-9 Domperidone

Domperidone
(CAS: 57808-66-9)

Domperidone is a medication developed by Janssen Pharmaceutica that acts as a peripherally-selective antagonist of the dopamine D2 and D3 receptors.

CAS 1841-19-6 Fluspirilene

Fluspirilene
(CAS: 1841-19-6)

Fluspirilene, with antipsychotic activity, is a non-competitive antagonist of agonist-activated L-type calcium channels (IC50 = 0.03 µM). Fluspirilene is also a...

Amitifadine hydrochloride
(CAS: 410074-74-7)

A Serotonin-Preferring Triple Reuptake Inhibitor for the Treatment of Major Depression, with the IC50 values for serotonin, norepinephrine and dopamine reuptake...

CAS 189744-94-3 Ro 10-5824 dihydrochloride

Ro 10-5824 dihydrochloride
(CAS: 189744-94-3)

Ro 10-5824, a D4R partial agonist, might have beneficial effects on attention and impulsivity by modulating baseline gamma activity in the frontal cortex.

CAS 20012-08-2 Trimopam

Trimopam
(CAS: 20012-08-2)

Trimopam is a dopamine receptor agonist.

ST-836 hydrochloride
(CAS: 1415564-68-9)

ST-836 hydrochloride, the hydrochloride salt form of verubulin, a dopamine receptor ligand that antiparkinsonian effect.

Chemical Structure

CAS 146-56-5 Fluphenazine DiHCl

Quick Inquiry

Verification code

Featured Items